# The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, Paragraph 8: Amendment of Schedule 4 (periodic fees for licences)

Extent: E+W+S+N.I.

In Schedule 4, in paragraph 1, in the definition of “limited use drug” for “which is in respect of an orphan medicinal product” substitute “ in respect of which an orphan marketing authorisation has been granted ”.

---
Source: https://www.legislation.gov.uk/uksi/2019/775/schedule/1/paragraph/8 (the official version)
Page: https://openlegislation.uk/human-medicines-amendment-etc-eu-exit-regulations-2019/schedule-1/paragraph-8
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.